West Pharmaceutical Services Stock Forecast, Price & News

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

Is West Pharmaceutical Services a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" West Pharmaceutical Services stock.
View analyst ratings for West Pharmaceutical Services or view top-rated stocks.

How has West Pharmaceutical Services' stock price been impacted by COVID-19 (Coronavirus)?

West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, WST shares have increased by 193.7% and is now trading at $434.13.
View which stocks have been most impacted by COVID-19.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,240,000 shares, an increase of 36.1% from the October 31st total of 911,300 shares. Based on an average daily volume of 358,700 shares, the short-interest ratio is presently 3.5 days. Approximately 1.7% of the shares of the company are sold short.
View West Pharmaceutical Services' Short Interest.

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for West Pharmaceutical Services.

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) issued its quarterly earnings data on Thursday, October, 28th. The medical instruments supplier reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.26. The medical instruments supplier had revenue of $706.50 million for the quarter, compared to analysts' expectations of $687.09 million. West Pharmaceutical Services had a net margin of 22.85% and a trailing twelve-month return on equity of 30.35%. West Pharmaceutical Services's revenue was up 28.9% compared to the same quarter last year. During the same period in the prior year, the company posted $1.15 EPS.
View West Pharmaceutical Services' earnings history.

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Friday, October 29th. Investors of record on Wednesday, November 10th will be paid a dividend of $0.18 per share on Wednesday, November 17th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.17%. The ex-dividend date of this dividend is Tuesday, November 9th. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.17.
View West Pharmaceutical Services' dividend history.

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.16%. West Pharmaceutical Services has been increasing its dividend for 28 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of West Pharmaceutical Services is 8.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 8.01% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.
View West Pharmaceutical Services' dividend history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2021 earnings guidance on Thursday, November, 4th. The company provided earnings per share (EPS) guidance of $8.400-$8.500 for the period, compared to the Thomson Reuters consensus estimate of $8.210. The company issued revenue guidance of $2.80 billion-$2.81 billion, compared to the consensus revenue estimate of $2.80 billion.

What price target have analysts set for WST?

1 brokerages have issued 12-month price objectives for West Pharmaceutical Services' stock. Their forecasts range from $475.00 to $475.00. On average, they anticipate West Pharmaceutical Services' share price to reach $475.00 in the next year. This suggests a possible upside of 9.4% from the stock's current price.
View analysts' price targets for West Pharmaceutical Services or view top-rated stocks among Wall Street analysts.

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the following people:

• Eric Mark Green, President, Chief Executive Officer & Director
• David A. Montecalvo, SVP, Chief Operations & Supply Chain Officer
• Bernard J. Birkett, Chief Financial Officer, Treasurer & Senior VP
• Silji Abraham, Chief Technology Officer & Senior Vice President
• Annette F. Favorite, Chief Human Resources Officer & Senior VP

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services CEO Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among West Pharmaceutical Services' employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

Who are some of West Pharmaceutical Services' key competitors?

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Quidel (QDEL), ICU Medical (ICUI), Neogen (NEOG), STAAR Surgical (STAA), Merit Medical Systems (MMSI), Haemonetics (HAE), Atrion (ATRI), Cerus (CERS), Meridian Bioscience (VIVO), OraSure Technologies (OSUR), Anika Therapeutics (ANIK) and Antares Pharma (ATRS).
View all of WST's competitors.

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.03%), Franklin Resources Inc. (4.02%), WCM Investment Management LLC (1.95%), Geode Capital Management LLC (1.81%), Invesco Ltd. (1.70%) and Bamco Inc. NY (1.69%). Company insiders that own West Pharmaceutical Services stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends for West Pharmaceutical Services.

Which major investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Goldman Sachs Group Inc., WCM Investment Management LLC, Artisan Partners Limited Partnership, Morgan Stanley, BlackRock Inc., Bank of New York Mellon Corp, and Victory Capital Management Inc.. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Quintin J Lai, and Silji Abraham.
View insider buying and selling activity for West Pharmaceutical Services or view top insider-selling stocks.

Which major investors are buying West Pharmaceutical Services stock?

WST stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Arrowstreet Capital Limited Partnership, Marshall Wace LLP, Panagora Asset Management Inc., Jupiter Asset Management Ltd., Eagle Asset Management Inc., Janus Henderson Group PLC, and Geode Capital Management LLC.
View insider buying and selling activity for West Pharmaceutical Services or or view top insider-buying stocks.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $434.13.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services has a market capitalization of $32.16 billion and generates $2.15 billion in revenue each year. The medical instruments supplier earns $346.20 million in net income (profit) each year or $8.06 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

West Pharmaceutical Services employs 9,200 workers across the globe.

Does West Pharmaceutical Services have any subsidiaries?

The following companies are subsidiares of West Pharmaceutical Services: Drug Delivery Assets From Plastef Investissements SA, Medimop Medical Projects Ltd., TGPR Holdings Limited, Tech Group Europe Limited (dba West), Tech Group Grand Rapids Inc. (dba West), The Tech Group Inc., W.P.S.F. Limited, WD SG Pte. Ltd., West Analytical Services LLC, West Contract Manufacturing LLC, West Pharma. Services IL Ltd., West Pharmaceutical Packaging (China) Company Ltd., West Pharmaceutical Packaging India Private Limited, West Pharmaceutical Products Ireland Ltd., West Pharmaceutical Services AZ Inc., West Pharmaceutical Services Argentina S.A., West Pharmaceutical Services Asia Ltd., West Pharmaceutical Services Australia Pty. Ltd., West Pharmaceutical Services Beograd d.o.o., West Pharmaceutical Services Brasil Ltda., West Pharmaceutical Services Colombia S.A.S., West Pharmaceutical Services Cornwall Limited, West Pharmaceutical Services Danmark A/S, West Pharmaceutical Services Delaware Acquisition Inc., West Pharmaceutical Services Deutschland GmbH Co KG, West Pharmaceutical Services France S.A.S., West Pharmaceutical Services Group Limited, West Pharmaceutical Services Hispania S.A., West Pharmaceutical Services Holding Danmark ApS, West Pharmaceutical Services Holding France SAS, West Pharmaceutical Services Holding GmbH, West Pharmaceutical Services Holding II GmbH, West Pharmaceutical Services Holding Ireland North Ltd., West Pharmaceutical Services Holding Ireland South Ltd., West Pharmaceutical Services Holding Japan GK, West Pharmaceutical Services Holdings Ltd., West Pharmaceutical Services Italia S.r.L., West Pharmaceutical Services Korea Ltd., West Pharmaceutical Services Lakewood Inc., West Pharmaceutical Services Normandie SAS, West Pharmaceutical Services Shanghai Medical Rubber Products Co. Ltd., West Pharmaceutical Services Singapore (Holding) Pte. Limited, West Pharmaceutical Services Singapore Pte. Ltd., West Pharmaceutical Services Switzerland GmbH, West Pharmaceutical Services Venezuela C.A., West Pharmaceutical Services Verwaltungs GmbH, West Pharmaceutical Services of Delaware Inc., and West Pharmaceutical Services of Florida Inc..

When was West Pharmaceutical Services founded?

West Pharmaceutical Services was founded in 1923.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is www.westpharma.com.

Where are West Pharmaceutical Services' headquarters?

West Pharmaceutical Services is headquartered at 530 HERMAN O. WEST DRIVE, EXTON PA, 19341.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at [email protected], or via fax at 800-345-9800.